SK Hynix beats rival Samsung Electronics in profits for 2025 for the first time ever, as the memory maker retains a lead in ...

About Samsung Epis Holdings Co., Ltd. As an investment holdings company dedicated to biopharmaceuticals and biotechnology, Samsung Epis Holdings aims to maximize corporate and shareholder value ...

Samsung Bioepis plans to secure 20 biosimilars in its products and pipeline by 2030 The new pipeline will include dupilumab, guselkumab, ixekizumab, fam-trastuzumab deruxtecan-nxki, vedolizumab, and ...

(BUSINESS WIRE )--Samsung Epis Holdings (KRX: 0126Z0) today shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference. "2026 is a monumental year for us, as we enter into a ...

Samsung Epis Holdings (KRX: 0126Z0) today shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference. This press release features multimedia ...

SAN FRANCISCO — Samsung Biologics CEO John Rim reiterated the Korean contract development and manufacturing organization, or CDMO, leader's strengths in production capacity, diversifying portfolio and ...

The pre-show events are already up and running at CES 2026 — the tech world’s biggest annual conference — and the news is already flowing. While the CES show floor doesn't officially open until ...

Folding phones have been stuck in a rut for a few years. We've seen concept smartphones playing with fresh folding designs, but ever since Samsung kickstarted the trend in 2019, there have only really ...

Samsung is working on a new foldable smartphone that's wider and shorter than the models that it's released before, according to Korean news site ETNews. The "Wide Fold" will compete with Apple's ...

Macy is a writer on the AI Team. She covers how AI is changing daily life and how to make the most of it. This includes writing about consumer AI products and their real-world impact, from ...

Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making manufacturing inroads in the U.S. by way of an acquisition. Samsung Bio’s U.S.